Pulmonary Thromboembolism: Incidence, Physiopthology, diagnosis and treatment

##plugins.themes.academic_pro.article.sidebar##

Published Jan 22, 2015
Download
pdf
Vol. 92 No. 7 (2014): Issue Jul 2014

##plugins.themes.academic_pro.article.main##

Mabrouk Bahloul
Anis Chaari
Hassen Dammak
Leila Abid
Daoud Salima
Hichem ksibi
Mohamed Samet
Hatem Kallel
Mounir Bouaziz

Abstract

Aim : The objective of this work was to review current data about the pathophysiology, clinical features, and treatment of pulmonary thromboembolism. Venous thromboembolism (VTE) remains a major challenge in hospitalised especially the care of critically ill patients. Pulmonary embolism (PE) is the major complication of VTE. By occluding the pulmonary arterial bed it may lead to acute life-threatening but potentially reversible right ventricular failure. The outcome of patients with PE is quite variable depending primarily on the cardio-respiratory status and the embolus size. PE is a difficult diagnosis that may be missed because of non-specific clinical presentation. Clinical signs include hypoxia, tachypnea, and tachycardia. Severe cases of untreated PE can lead to circulatory instability, and sudden death. However, in ICU, most of patients require sedation and mechanical ventilation. The clinical manifestations usually observed in this condition (PE) cannot be exhibited by these patients and clinical presentation is usually atypical. For these reasons, the diagnosis of PE is usually suspected when un-explicated hypoxemia and/or shock and arterial hypotension were observed. Positive diagnosis is based on these clinical findings in combination with laboratory tests and imaging studies. D-dimer testing is of clinical use when there is a suspicion of DVT or pulmonary embolism PE. In Emergency department, a negative D-dimer test will virtually rule out thromboembolism with a negative predictive value at 95 to 98%. In massive and submassive PE, dysfunction of the right side of the heart can be seen on echocardiography. While the gold standard for diagnosis is the finding of a clot on pulmonary angiography, CT pulmonary angiography is the most commonly used imaging modality today. When the diagnosis is confirmed, anticoagulant therapy is the mainstay of treatment. Acutely, supportive treatments a pivotal role in the management of patients with PE. Severe cases may require thrombolysis with drugs such as tissue plasminogen activator (tPA) or may require surgical intervention via pulmonary thrombectomy. Prevention is highly warranted.

Keywords:

Pulmonary Embolism, Deep vein thrombosis,Anticoagulation, Prevention.

##plugins.themes.academic_pro.article.details##

References

  1. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardio vasc Dis. 1975; 17: 259 -270.
  2. Oger E. Incidence of venous thromboembolism:a community-based Study in Western France. EPI - GETBO Study Group. Group d'Etude de la thrombose de Bretagne Occidentale. Throm Haemost. 2000; 83: 657- 660.
  3. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126:338S-400S.
  4. Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg. 1991; 78:849-52.
  5. Goldhaber SZ , Hennekens CH,Evans DA, et al. Factors associated with corrrect antemortem diagnosis of major pulmonary embolism. Am J Med.1982; 73:822-826.
  6. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy.Chest.1995; 108:978-981.
  7. Timothy A M., Heather F. New Modalities for the Diagnosis of Deep Venous Thrombosis and Pulmonary Embolism. Clinical Pulmonary Medicine. 2005; 12 : 359-362
  8. Lucena J, Rico A, Vázquez R et al. Pulmonary embolism and suddenunexpected death: Prospective study on 2477 forensic autopsies performed at the institue of Legal Medicine in Seville. J Forensic Leg Med.. 2009; 16: 196-201.
  9. Mostafazadeh B, Ahmad EF, Zavvareh HT, Gharadaghi J, Saleki S. Prevalence of pulmonary thromboemboli among referred cadavers having hospitalization records to Tehran Legal Medicine Center. J Forensic Leg Med. 2008 ; 15: 322-4.
  10. Aujesky D, Smith KJ, Cornuz J, Roberts MS. Cost-effectiveness of lowmolecular- weight heparin for treatment of pulmonary embolism. Chest. 2005; 128:1601-10.
  11. Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW 3rd.Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009; 66:1436-40..
  12. K. Hogg, D Dawson and K Mackay-Jones. Out patient diagnosis of pulmonary embolism: the MIOPED (Manchester Investigation of Pulmonary Embolism Diagnosis) Study.Emerg.Med.J. 2006; 23;123-127.
  13. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008; 28:387-91.
  14. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med. 2005; 33: 1565-1571.
  15. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001; 161: 1268-79.
  16. Bagot CN, Arya R. "Virchow and his triad: a question of attribution. Br. J. Haematol. 2008; 143: 180-90
  17. Armand-Perroux A, Barrelier M-T. La thrombose veineuse : quoi de neuf ? Réanimation. 2008 ; 17 : 736-744.
  18. Cushman M. Epidemiology and Risk Factors for venous Thrombosis. Semin Hematol. 2007; 44: 62-69.
  19. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008; 29: 2276- 2315.
  20. Hermanides J, Cohn DM, Devries JH et al.Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study. J Thromb Haemost. 2009; 7: 945-9.
  21. Breuer J, Meshcig R, Breuer HWM, Arnold G. Effects of serotonin on the cardiopulmonary circulatory system with and without 5- HT2-receptor blockade by ketanserin. J Cardiovasc Pharmacol. 1985; 7: S64-S66.
  22. Tibbutt DA, Davies JA, Anderson JA, Fletcher EW, Hamill J, Holt JM et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Br Med J. 1974; 1: 343-347.
  23. J.L.DIEHL, A.Mercat. Gestion de l'embolie pulmonaire grave. Rev Mal Respir.1999 ; 16: 996-1006.
  24. Samuel Z.Goldhaber,M.D. Pulmonary Embolism, The New England Journal of Medicine 1998,339:93-104.
  25. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998; 158:585-593.
  26. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).Lancet. 1999; 353:1386-89.
  27. Laporte S, Mismetti P, Décousus H, et al. Clinical predictors for fatal pulmonary embolism findings from the Riete Registry. Circulation. 2008; 117; 1711-1716.
  28. Bayrd RW, Cutz E. Sudden and unexpected death in infancy and childhood due to pulmonary thromboembolism. An autopsy Study. Arch Pathol lab Med. 1990; 114:142-4.
  29. Tavil B, Kuskonmaz B, Kiper N, Cetin M, Gumruk F, Gurgey A. Pulmonary thromboembolism in childhood: a single-center experience from Turkey. Heart Lung. 2009; 38:56-65.
  30. Burck JK, Connors RH, Coon WW, Wantraub WH, Wesley JR, Coran AG. Pulmonary embolisme in children. J pediatr Surg 1981; 16:385-91.
  31. Paul D; Stein, MD, Sarah E. Fowler,Ph.d, Lawrence R. For the PIOPED II Investigators. Multidetector Computed Tomography for acute pulmonary Embolism. N Engl J Med. 2006; 354; 2317-27.
  32. Heit JA, Silvertein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton 3 rd LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population -based case-Control study. Arch Intern Med .2000; 160:809- 815.
  33. Muscedere JG, Heyland DK, Cook D. Venous thromboembolism in critical illness in a community intensive care Unit. Journal of critical care. 2007; 22: 285-289.
  34. Cohen AT, Tapson VF, Bergman JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE Study): amultinational crosssectional study. Lancet. 2008; 371:387-94.
  35. Todd JL, Tapson VF. Thrombolytic therapy for acute pulmonary embolism: a critical appraisal. Chest. 2009 ; 135:1321-9.
  36. Sharma M, Degoricija V, Legac A, Gradiser M, Vucicević Z. The epidemiology and diagnostic approach to acute pulmonary embolism in the university hospital. Coll Antropol. 2009; 33: 57-63.
  37. Slobogean GP, Lefaivre KA, Nicolaou S, O'Brien PJ. A systematic review of thromboprophylaxis for pelvic and acetabular fractures. J Orthop Trauma. 2009 ; 23: 379-84.
  38. G.Meyer, O.Sanchez. Embolie Pulmonaire. EMC-Aneshésie Réanimation 1; 2004; 54-68.
  39. Knudson MM, Collins JA, Goodman SB, et al. Thromboembolism following multiple trauma. J Trauma. 1992; 92:2-11.
  40. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS.. thromboembolism After Trauma. An Analysis of 1602 Episodes From the American College of Surgeons. National Trauma Data Bank. Annals of Surgery. 2004; 240:490-6.
  41. Shackford SR, Davis JW, Hollingsworth-Frielund P, et al. Venous thromboembolism in patients with major trauma. Am J Surg. 1990; 159: 365-369.
  42. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma 1999; 47:719-23.
  43. Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA, et al. A comparison of low dose heparin with low-molecular weight-heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335:701-7.
  44. R.Selby, W.Geerts, F.A. Ofosu, et al. Hypercoagulabiliy after trauma: Hemostatic changes and relationship to venous thromboembolism.Thromb Res. 2009;124: 281-7
  45. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994; 331: 1601-6.
  46. Norwood SH, McAuley CE, Berne JD,et al. Prospective Evaluation of the Safety of Enoxaparin Prophylaxis for Venous Thromboembolism in Patients With Intracranial Hemorrhagic Injuries. Arch Surg. 2002; 137:696-702.
  47. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S.. The Risk of Recurrent Venous Thromboembolism in Men and Women. N Engl J Med 2004; 350:2558-63.
  48. Stein PD, Sostman HD, Bounameaux H et al. Challenges in the Diagnosis Acute Pulmonary Embolism. Am J Med. 2008; 121: 565-571.
  49. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest 2008; 133:381S—453S.
  50. Tetri S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Savolainen ER, Hillbom M. Safety of low-dose subcutaneous enoxaparine for the prevention of venous thromboembolism after primary intra cerebral haemorrhage. Thrombosis Research. 2008; 123: 206-212.
  51. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of legs after strokes: Part I - Incidence and predisposing factors. Part II - Natural history. Br Med J. 1976; 1:1178-83.
  52. Kokturk N, Demir N, Oguzulgen IK, Demirel K, Ekim N. Fever in pulmonary embolism. Blood Coagul Fibrinolysis. 2005; 16: 341-7.
  53. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ. 1992; 305(6853):567-74.
  54. Huisman MV, Buller HR, Ten Cate JW, Van Royen EA, Vreeken J, Kersten MJ, Bakx R. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest. 1989;95:498- 502.
  55. Meneveau N, Vuillemenot A, Bassand J.-P. L'Embolie Pulmonaire. Evaluation clinique démarche diagnostique et stratégie thérapeutique. Boeringer Ingelheim France.R and J. Edition médicale 1997 ; 11 - 53
  56. Bahloul M, Chaari A, Kallel H, Abid L, Hamida CB, Dammak H, Rekik N, Mnif J, Chelly H, Bouaziz M. Pulmonary embolism in intensive care unit: Predictive factors, clinical manifestations and outcome. Ann Thorac Med. 2010; 5: 97-103.
  57. Bell WR,Simon TL, De Mets DL. The clinical features of submassive and massive pulmonary embolism.Am J Med, 1977; 62:355-360.
  58. Calvo-Romero JM, Pérez-Miranda M, Bureo-Dacal P. Wheezing in patients with acute pulmonary embolismwith and without previous cardiopulmonary disease. Eur J Emerg Med. 2003; 10: 288-9.
  59. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990; 263:2753- 2759.
  60. Elliot CG. Pulmonary physiology during pulmonary embolism. Chest. 1992;101:163S-171S.
  61. Page Y, Orliguet G. Maladie thromboembolique en réanimation: interruption cave et embolectomie. Réanimation. 2001;10: 499-504.
  62. Stein PD, Willis PW 3rd, DeMets DL. History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. Am J Cardiol, 1981; 47:218.
  63. The Urokinase-Streptokinase Pulmonary Embolism Trial.Phase 2 results.A cooperative study. JAMA. 1974.223:1606.
  64. Miniati M, Bottai M, Monti S. Comparison of 3 Clinical Models for Predicting the Probability of Pulmonary Embolism. Medicine (Baltimore). 2005; 84:107-114.
  65. Guidelines on diagnosis and management of acute pulmonary embolism. Task force on pulmonary embolism, European Society of Cardiology. Eur Heart J. 2000; 21:1301-36.
  66. Jardin F. Le ventricule droit dans l'Embolie Pulmonaire. Réanimation 2001; 10:225-31.
  67. Geibel A, Zehender M, Kasper W, Olschewski M, Klima C, Konstantinides SV. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur Respir J. 2005; 25: 843-848.
  68. Kenneth E. Wood.Major Pulmonary Embolism: Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism.Chest. 2002; 121: 877-905.
  69. Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry. Circulation. 1997; 96: 882-8.
  70. Victor F.Tapson,M.D. Acute pulmonary Embolism. Medical progress. N Engl J Med. 2008; 358:1037-52.
  71. Fedullo PF, Tapson VF. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med. 2003; 349:1247-56.
  72. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83:416-420.
  73. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006; 144: 165- 171.
  74. Klok FA, Kruisman E, Spaan J et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost. 2008; 6: 40- 44.
  75. Kruip MJ, Leclercq MG, van der Heul C, Prins MH, Büller HR. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med. 2003 ; 138: 941-951.
  76. Meyer G, Chopin C, Remy J, Slama M. Diagnostic de l'Embolie Pulmonaire sur poumon pathologique (insuffisance respiratoire chronique obstructive), sous respiration artificielle et chez le patient jugé intransportable. Réanimation. 2001; 10: 478-83.
  77. Stein PD, Goldhaber SZ, Henry J W. Arterial blood gas analysis in the assessement of suspected acute pulmonary embolism. Chest. 1995; 107: 139-143.
  78. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of the acute thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004; 140:589—602.
  79. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of the acute thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004; 140:589—602.
  80. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med J. 2001; 135:98 -107.
  81. Deborah A.Quinn, Robert.B.Fogel, Synthia. D-Dimère in the Diagnosis of pulmonary embolism. Pulmonary critical unit care.1999; 153:1445-1449.
  82. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353:190-195.
  83. Segal JB, Streiff MB, Hofmann LV,Thrton K,Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007; 146:211-22.
  84. Elliott CG, Goldhaber SZ, Visani L, DeRosa M. Cooperative Pulmonary Embolism Registry Embolism: Results From the International Chest Radiographs in Acute Pulmonary. Chest 2000; 118; 33-38.
  85. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998; 129:1044-1049.
  86. Perrier A, Bounameaux H. Ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1998; 128:243-245.
  87. Jardin F, Dubourg O, Bourdarias JP. Echocardiographic pattern of acute cor pulmonale. Chest. 1997; 111: 209-17.
  88. Stavors Konstantinidis. Pulmonary embolism:impact of right ventricular dysfunction. Current opinion in cardiology. 2005, 20:496-501.
  89. Kasper W, Konstantinides, Geibel A et AL. Managements strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997; 30: 1165-71.
  90. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J. 1997; 134: 479- 87
  91. Alderson PO, Martin EC. Pulmonary embolism: diagnosis with multiple imaging modalities. Radiology. 1987; 257:3257-3259.
  92. McNeil BJ. A diagnostic strategy using ventilation-perfusion studies in patients suspect for pulmonary embolism. J Nucl Med. 1976; 17:613- 616. pulmonary embolism. J Nucl Med. 1978; 19:164-171.
  93. Alderson PO, Doppman JL, Diamond SS et al. Ventilation-perfusion lung imaging and selective pulmonary angiography in dogs with experimental pulmonary embolism. J Nucl Med. 1978; 19:164-171.
  94. Kispper MS, Moser KM, Kortman KE et al. Long term follow-up of patients with suspected pulmonary embolism and a normal lung scan. Chest. 1982;82:411-415.
  95. Rémy J, Rémy-Jardin M, Giraud F et al. Le balayage spiralé volumique et ses applications en pathologie thoracique. Rev Mal Resp, 1994;11:13- 27. thoracique. Rev Mal Resp, 1994;11:13- 27.
  96. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism:diagnosis with spiral volumetric CT with the singlebreath- hold technique:comparison with pulmonay angiography. Radiology. 1992;185:381-387.
  97. Goodman LR,Curtin JJ, Mewissen MW,et al. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphie diagnosis : Helical CT Roentgnol.1995; 164:1369-1374.
  98. Van Rossum AB, Pattynama PM, Tjin ER et al. Pulmonary embolism validation of spiral Ctangiography in 149 patients.Radiology.1996;201: 467-470. 164:1369-1374.
  99. Goodman LR, Lipchik RJ, Kuzo RS, et al. Subsequent pulmonary embolism: risk after a negative helical CT pulmonary angiogramprospective comparison with scintigraphy. Radiology.2000; 215:535- 542.
  100. Mercat M, Orliaguet G. Traitement symptomatique de la défaillance cardiorespiratoire de l'Embolie Pulmonaire grave. Réanimation. 2001; .10:495-498.
  101. Belenkie I, Dani R, Smith ER, Tyberg JV. Effects of volume loading during experimental acute pulmonary embolism. Circulation. 1989; 80: 178-88.
  102. Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology. 1984; 60: 132-5.
  103. Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlation. Circulation. 1981; 63: 87-95.
  104. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med. 1999; 27: 540-4.
  105. Ducas J, Stitz M, Gu S, Schick U, Prewitt RM. Pulmonary vascular pressure-flow characteristics, effects of dopamine before and after pulmonary embolism. AmRevRespir Dis. 1992 ; 146 :307-12.
  106. Sharma GV, McIntyre KM, Sharma S, Sasahara AA.. Clinical and hemodynamic correlates in pulmonary embolism. Clin Chest Med. 1984; 5: 421-37.
  107. Smulders YM. Pathophysiology and treatment of heamodynamic instability in acute pulmonary embolism:the pivotal role of pulmonary vasoconstricion .Cardiovasc Res. 2000; 48:23-33.
  108. Molloy DW, Lee KY, Jones D, Penner B, Prewitt RM. Effects of noradrenaline and isoproterenol on cardiopulmonary function in a canine model of acute pulmonary hypertension. Chest. 1985 ; 88 : 432-5.
  109. Molloy WD, Lee KY, Girling L, Schick U, Prewitt RM. Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis. 1984; 130: 870-4.
  110. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
  111. Blondon M, Bounameaux H, Righini M. Treatment strategies for acute pulmonary embolism. Expert Opin Pharmacother. 2009; 10:1159-71.
  112. Schulman S, Lockner D, Bergstrom K, Blomback M. Intensive initial oral anticoagution and shorter heparin treatment in deep venous thrombosis. Thromb Haemosts. 1984;52:276-280.
  113. Charbonnier B. Indications des thrombolytiques. Réanimation. 2001; 10: 484-6.
  114. Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, et al. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2. J Am Coll Cardiol. 1992; 20 : 520-6.
  115. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997 ; 111 : 1241-5.
  116. Samuel Z.Goldhaber and C.Gregory,Elliott. Acute pulmonary embolism:Part I:Epidemiologiy,Pathophysiology,AND diagnosis. Circulation. 2003; 108; 2726-2729.
  117. Hirsch J, Hoak J. Management of deep vein thrombosis and pulmonary embolism a statement for healthcare professionals. Circulation. 1996; 93: 2212-45.
  118. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001 ; 119 : 176S-93S.
  119. Decousus H, Leizorovicz A, Parent F, Page Y, Tardi B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998; 338: 409-15.
  120. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters: indications, safety, and effectiveness. Arch Intern Med. 1992; 152: 1985- 94.
  121. Tardy B, Mismetti P, Page Y, Decousus H, Da Costa A, Zeni F, et al. Symptomatic inferior vena cava filter thrombosis : clinical study of 30 consecutive cases. Eur Respir J. 1996; 9 : 2012-6.
  122. Ginsberg JS. Management of venous thromboembolism. N Engl J Med. 1996; 335:1816-28.
  123. Gowthami M. Arepally,M.D.,and Thomas L. Ortel,M.D. Ph.D. Heparininduced thrombocytopenia. N.Engl J Med. 355; 8:809-817.
  124. Bruno Besse, Nicolas Lellouche. CAT devant une HTAP. Cardiologie et maladies vasculaires. édition 2005-2006. pp : 151-154.
  125. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006; 113:2011- 2020.
  126. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000; 160:761-68.
  127. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost. 2002; 88: 407-414.
  128. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med. 2003; 139:19-25.
  129. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA. A population-based prospective of the hospital incidence and case-fatality of deep vein thrombosis and pulmonary embolism, Arch Inter Med. 1991; 151: 933-8.
  130. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA. A population-based prospective of the hospital incidence and case-fatality of deep vein thrombosis and pulmonary embolism, Arch Inter Med. 1991; 151: 933-8.
  131. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992; 326: 1240-45.
  132. Barrit DW, Jordan SC. Clinical features of pulmonary embolism. Lancet 1961, 1:729-32.
  133. Barrit DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. Lancet . 1960; 1:1309-12.
  134. Simonneau G, Sors H, Charbonnier B et al. A comparison of lowmolecular- weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med. 1997; 337:663-9.
  135. THE COLOMBUS INVESTIGATORS: Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med. 1997; 337:657-62.
  136. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ, Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma. 1995; 9:1-7